Latest Innovation News

Eden Innovations is expanding the use of its EdenCrete® concrete additives across major infrastructure projects in Colorado, including a high-rise, public pools, and a massive highway upgrade.

Richmond Vanadium Technology slows key project activities and reshapes its leadership team to navigate a prolonged period of low vanadium prices while advancing battery technology development.

Eden Innovations is progressing toward the sale of its 65-acre industrial property in Augusta, Georgia, with settlement expected in August pending final permits. The deal will significantly reduce the company’s debt and interest expenses.

Activeport Group has launched its version 3.0 GPU orchestration software, enabling a major expansion in cloud gaming capacity with a large-scale deployment supporting Radian Arc and Jio’s gaming platforms.

Magnetic Resources NL has significantly increased its Lady Julie Gold Project resource to 2.14 million ounces, underpinning robust project economics and setting the stage for a Definitive Feasibility Study due in Q2 2025.

Kula Gold reports standout high-grade gold intercepts up to 31.3 grams per tonne from ongoing drilling at its Mt Palmer project, advancing the asset toward a potential resource estimate.

Ardea Resources reports significant progress on the Kalgoorlie Nickel Project’s Definitive Feasibility Study, completing key drilling and advancing permitting to support a multi-decade nickel-cobalt operation.

PointsBet Holdings has highlighted that Betr Entertainment’s proposed takeover offer undervalues its shares compared to MIXI Australia’s superior $1.20 cash bid, intensifying the takeover battle.

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

AML3D has opened a cutting-edge Wire-Arc Additive Manufacturing facility in Ohio, enhancing U.S. defense production and supporting the AUKUS partnership. The new site aims to supply critical components for the Virginia-class submarine program while creating local jobs.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.